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Purpose. To determine the incidence of keratoconus and to determine its possible association with common systemic diseases
using a nationwide cohort. Methods. ,is retrospective nationwide cohort study included 1,025,340 subjects from the Korean
National Health Insurance Service-National Sample Cohort database from 2004 to 2013. Estimates for incidence rates of
keratoconus were identified. After 1 : 5 matching using propensity scores, associations between keratoconus and certain systemic
comorbidities were determined using multivariate logistic regression analysis. Results. ,e incidence during the same period was
15.1 cases per 100,000 person-years. Adjusted logistic regression analysis after propensity score matching revealed significant
associations between keratoconus and allergic rhinitis (odds ratio (OR): 1.86; 95% confidence interval (CI): 1.63–2.13; p< 0.001),
asthma (OR: 1.20; 95% CI: 1.06–1.36; p< 0.001), atopic dermatitis (OR: 1.33; 95% CI: 1.13–1.56; p< 0.001), and diabetes mellitus
(DM) (OR: 1.35; 95% CI: 1.15–1.58; p< 0.001). Conclusion. Estimates of the incidence of keratoconus may help in the planning of
eye-care policies, and the results of this study determined the associations between allergic diseases and keratoconus. Conflicting
results regarding the association between keratoconus and DM should be further evaluated.
1. Introduction
Keratoconus is a chronic, progressive, noninflammatory
ectatic corneal condition that leads to decreased visual acuity
because of increased myopia and irregular astigmatism.
,ese conditions are known to affect patients 18–40 years of
age.,e severity of the disease varies from a subclinical stage
to a severely progressive stage, resulting in corneal scarring,
perforation, or even blindness [1, 2]. Treatment also varies
from wearing glasses or rigid contact lenses to complex
surgical procedures such as keratoplasty to restore visual
acuity [1].
,e previously reported annual incidence of keratoconus
varied greatly from 1.3 to 32.3 cases per 100,000, according
to the country where the study was conducted [3]. ,is wide
range of reported estimates may be due to ethnic differences,
differences in accessibility because of regional differences,
and discordant study designs [3]. Additionally, with recent
advances in refractive surgery and the development of
delicate corneal topographic devices and software, kerato-
conus is diagnosedmore frequently than before, especially in
the early subclinical stages, which may also account for some
disparities in the estimates of annual incidence of kerato-
conus [4, 5].
While the pathophysiology of keratoconus is currently
not clearly known, a few previous studies investigated risk
factors for keratoconus to clarify its pathophysiological
mechanism [4]. ,e reported risk factors for keratoconus
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include ocular allergy, atopic dermatitis, connective tissue dis-
orders, and Down syndrome [6–9]. Contradictory results exist
regarding the role of diabetes mellitus (DM) in the development
of keratoconus, with the possibility of increasing or reducing the
risk of developing corneal ectasia [10–12]. Considering ethnic
differences in the incidence of keratoconus, possible associations
between systemic comorbidities and keratoconus should be
clearly determined in patients with Asian ethnicity, and reports
regarding the risk factors for keratoconus in the Republic of
Korea should be clearly defined.
Based on these considerations, we evaluated the inci-
dence of keratoconus and investigated associations between
various systemic conditions and keratoconus using data
from a nationwide sample of approximately 1 million res-
idents from the National Health Insurance Service-National
Sample Cohort 2002–2013 (NHIS-NSC 2002-2013).
2. Methods and Materials
2.1. Database. ,is study used data from the NHIS-NSC
2002–2013. ,e Korean National Health Insurance Service
(KNHIS), which is a mandatory single medical insurer
system, has been managing national health insurance in the
Republic of Korea since 1989. All citizens are required to
enroll in the system, and it provides nearly the entire
healthcare coverage in the Republic of Korea. ,e KNHIS
developed the NHIS-NSC for research purposes, which
contains personal demographic records for all medical in-
formation related to insurance claims. ,e NHIS-NSC
sampled 1,025,340 individuals from among 46,605,433 in-
dividuals in the NHID (2.2%) in 2002 and followed them
until 2013 [13]. ,e study design was approved by the In-
stitutional Review Board of Soonchunhyang University
Bucheon Hospital, Gyeonggi-do, Republic of Korea. ,is
study adhered to the tenets of the Declaration of Helsinki,
and the need for written informed consent was waived.
2.2. Selection of Study Samples. To exclude chronic kerato-
conus patients, we excluded patients who were diagnosed
with keratoconus in 2002 and 2003 and included patients
who were diagnosed with keratoconus from 2004. ,e
keratoconus cases were identified as patients who had the
following Korean Classification of Diseases code as the main
diagnosis code: H186 and H198, and had a keratometry
measurement code (E6870).
Control subjects were selected from individuals who did
not have keratoconus diagnosis codes, each year, using
propensity scores with nearest neighbor matching in a 1 : 5
ratio to keratoconus patients [14]. Propensity scores were
calculated using sociodemographic parameters, including
age group (≤19, 20–59, and ≥60 years of age), sex, income
(≤40th, 41st–70th, and ≥71st percentiles), residential area
(urban, metropolitan cities, cities, rural, and all other areas),
and year of enrollment.
2.3. Incidence andComorbidity. In the matched populations,
we compared the incidence of keratoconus. ,e earliest date
of the keratoconus diagnosis was defined as the index date
and the incident time, and the patient was considered an
incident case in that corresponding year. Comorbid con-
ditions included allergic rhinitis (codes), asthma (codes),
atopic dermatitis (codes), aortic dissection (codes), sleep
apnea (codes), collagen vascular diseases (codes), DM (codes
E10–E14), mitral valve prolapse (codes), and Down syn-
drome (code) that were diagnosed between 2002 and 2008.
Because the purpose of this study was to investigate asso-
ciations between systemic diseases and keratoconus, and not
necessarily to identify causative relationships between the
conditions, we included cases and controls without con-
sidering the date when the diagnosis was made during the
study period.
2.4. Statistical Analysis. Baseline characteristics are
expressed as the mean and standard deviation or number
and percentage. ,e chi square test was used to compare
groups. Multivariate logistic regression analysis was per-
formed to calculate odds ratio (OR) with a 95% confidence
interval (CI) to evaluate the potential association between
keratoconus and various systemic diseases. ,e variables
included in multivariate analyses were age, sex, income,
residential area, and systemic diseases of interest that were
previously reported to be associated with keratoconus. All
statistical analyses were conducted using SAS software,
version 9.4 (SAS Institute, Cary, NC, USA), and R 3.4.1 (R
Project for Statistical Computing, Vienna, Austria).
3. Results
,e number of patients diagnosed with keratoconus from
2004 to 2013 came to 1,552, and 7,760 controls were included
for comparison. ,e incident cases were 46 (4.5%), 30
(3.0%), 20 (2.0%), 40 (3.9%), 49 (4.9%), 76 (7.6%), 33 (3.3%),
48 (4.8%), 37 (3.7%), and 8 (0.8%) in 2004, 2005, 2006, 2007,
2008, 2009, 2010, 2011, 2012, and 2013, respectively (Table 1
and Figure 1).
Table 2 shows the baseline characteristics of the study
population. A total of 1,552 keratoconus patients and 7,760
subjects from the control group were included for analysis.
,ere were no significant differences in demographic
characteristics used for matching, including age group, sex,
income, residential area, and the year of enrollment. Among
the systemic diseases that were previously reported to be
associated with keratoconus, allergic rhinitis (p< 0.001),
asthma (p< 0.001), and atopic dermatitis (p< 0.001) were
more prevalent in the keratoconus group, while DM was
more prevalent in the comparison group (p< 0.001). Other
diseases, including aortic dissection, sleep apnea, and col-
lagen vascular diseases, did not show any significant dif-
ference between groups. Mitral valve prolapse and Down
syndrome were excluded for further analysis because the
prevalence in both groups was not measurable or very low.
Using multivariate logistic regression analysis, individ-
uals with allergic diseases, including allergic rhinitis (OR:
1.86; 95% CI: 1.63–2.13; p< 0.001), asthma (OR: 1.20; 95%
CI: 1.06–1.36; p � 0.005), and atopic dermatitis (OR: 1.33;
95% CI: 1.13–1.56; p< 0.01), had significant associations
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with keratoconus after adjusting for confounding factors
(Table 3). However, aortic dissection and sleep apnea did not
show a significant association with higher or lower odds of
keratoconus. Keratoconus also showed a significantly pos-
itive association with DM (OR: 1.35; 95% CI: 1.15–1.58;
p< 0.001). No significant association was found for de-
mographic factors because they were used for propensity
matching.
4. Discussion
In the present study, the incidence rate of keratoconus
ranged from 0.8 to 7.5 per 100,000 person-years during 2004
and 2013. After propensity score matching, logistic re-
gression analysis showed significant associations with the
presence of allergic rhinitis, asthma, and atopic dermatitis.
However, no relevant result appeared in systemic diseases
such as aortic dissection, sleep apnea, collagen vascular
diseases, mitral valve prolapse, and Down syndrome.
Lee et al. [15] studied the epidemiology of keratoconus,
which was designed in a similar manner but showed dif-
ferent results compared to our results. In contrast to our
results, allergic conjunctivitis was the only risk factor for
keratoconus in the Republic of Korea population in their
study. Importantly, allergic rhinitis was not a risk factor for
keratoconus, which differed from other studies, including
our results. We suggest the difference in results was because
their databases were from 2002 and 2015. ,ey also used
only age and household income for propensity scores, while
in this study, we included age, sex, income, residential area,
and year of enrollment to exclude any potential confounding
factors that may affect the outcome. Additional studies are
needed to confirm the results of various studies.
An epidemiological study from Germany reported that
the incidence of keratoconus per 100,000 person-years was
13.3 (1 : 75,000), which showed a high incidence rate com-
pared to our study [16]. ,e reason for this disparity may be
due to the diagnostic codes, which may have included other
conditions, as well as regional and racial differences among
the patients included in the study. Another previously re-
ported study in the Republic of Korea, which was a pop-
ulation-based study using the Korean Health Insurance
Review and Assessment database, reported an incidence of
keratoconus of 5.56 cases per 100,000 person-years [17],
which was similar to the result from our study.
,e conclusions reached in our study showed a signif-
icant association between allergic diseases including allergic
rhinitis, asthma, atopic dermatitis, and the presence of
keratoconus. An earlier study also reported that atopic
diseases including asthma, vernal keratoconjunctivitis,
atopic keratoconjunctivitis, and seasonal or perennial al-
lergic keratoconjunctivitis were associated with keratoconus,
and their prevalence in keratoconus patients had a higher
incidence than the control group [18]. ,e most common
cause of keratoconus is thought to be frequent eye rubbing,
and pruritis associated with atopy and other allergic con-
ditions leads to eye rubbing [19–24]. As a result of me-
chanical rubbing, friction occurs between the palpebral
conjunctiva and corneal epithelium, which may eventually
lead to corneal thinning, finally resulting in tissue bulging
and a cone-shaped structure. Another possible theory
suggests that the association between keratoconus and an
allergic condition involves activation of the same human
leukocyte antigens [19].
Importantly, our study showed a positive association
between keratoconus and DM. Regarding the association
Table 1: Estimated incidence rate (per 100,000 person-years) of keratoconus in South Korea during 2004–2013.
Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Population 1,016,391 1,016,646 1,001,891 1,020,593 1,000,601 998,348 1,001,898 1,006,332 1,011,013 1,014,622
Incidence 46 30 20 40 49 76 33 48 37 8






















Figure 1: Incidence of keratoconus from 2004 to 2013 in Korea.
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between keratoconus and DM, there are several studies that
have reported patient groups with DM showing lower odds
of having keratoconus, when compared to groups without
diabetics, with reduced odds ranging from 20% to 78%
[10, 25, 27]. Studies reporting a low incidence of keratoconus
in diabetics suggested that the results were due to thicker
corneas in patients with diabetics. ,ere are two hypotheses
regarding the high stromal volume in diabetics. First, Ishino
et al. [28] investigated corneal autofluorescence using a
fluorophotometer and found that corneal autofluorescence
in diabetics was higher than that of controls. ,ey suggested
mitochondrial dysfunction, water retention in the stroma,
and increased corneal volume after observing the corneal
autofluorescence. Another hypothesis suggested that high
glucose levels stimulate nonenzymatic glycosylation, which
leads to collagen cross-linking, stromal strengthening, and
the prevention of age-related thinning [28]. However,
Kosker et al. reported contradictory results in their case-
control study, showing that patients with DM were more
likely to suffer from keratoconus compared to normal
controls [12]. ,e results of the present study are consistent
with those of Kosker et al., showing a significant positive
association between keratoconus and DM. However, further
studies with a similar design are needed to confirm these
results.
We also investigated the association between kerato-
conus and other systemic comorbidities, which were pre-
viously reported to be related with the disease. Previous
studies have reported higher odds of keratoconus in patients
with Down syndrome, mitral valve prolapse, collagen vas-
cular disease, and sleep apnea [28–30]. However, the
number of patients with these conditions was very low or
absent in the cohort used for the analysis, so associations
could not always be determined. Further studies with more
patients are needed, therefore, to confirm the results.





control (N, %) Total p value
1,552 100.0% 7,760 100.0% 9,312
Allergic rhinitis
No 342 22.0 2,810 36.2 3,152 <0.001
Yes 1,210 78.0 4,950 63.8 6,160
Asthma
No 1,048 67.5 5,833 75.2 6,881 <0.001
Yes 504 32.5 1,927 24.8 2,431
Atopic dermatitis
No 1,296 83.5 6,858 88.4 8,154 <0.001
Yes 256 16.5 902 11.6 1,158
Aortic dissection
No 1,550 99.9 7,753 99.9 9,303 0.655
Yes 2 0.1 7 0.1 9
Sleep apnea
No 1,548 99.7 7,746 99.8 9,294 0.527
Yes 4 0.3 14 0.2 18
Collagen vascular diseases
No 1,550 99.9 7,754 99.9 9,304 0.527
Yes 2 0.1 6 0.1 8
Diabetes mellitus
No 1,254 80.8 6,636 85.5 7,890 <0.001
Yes 298 19.2 1,124 14.5 1,422
Mitral valve prolapse
No 1,552 100.0 7,757 100.0 9,309 0.439
Yes — 0.0 3 0.0 3
Down syndrome
No 1,552 100.0 7,759 100.0 9,311 0.655
Yes — 0.0 1 0.0 1
Variables for matching
Sex
Male 678 43.7 3,390 43.7 4,068 1.000
Female 874 56.3 4,370 56.3 5,244
Age group
≤19 233 15.0 1,165 15.0 1,398 1.000
20–59 1,045 67.3 5,225 67.3 6,270
≥60 274 17.7 1,370 17.7 1,644
Income
Low 302 19.5 1,510 19.5 1,812 1.000
Middle 554 35.7 2,770 35.7 3,324
High 696 44.8 3,480 44.8 4,176
Residential area
Metropolitan 130 8.4 650 8.4 780 1.000
City 401 25.8 2,005 25.8 2,406
Rural 1,021 65.8 5,105 65.8 6,126
Table 3: Logistic regression model estimating associations of
covariates with keratoconus.
Variables Odds ratio(95% CI) p value
Allergic rhinitis No 1.000 (reference)
Yes 1.86 (1.63–2.13) <0.001
Asthma No 1.000 (reference)
Yes 1.20 (1.06–1.36) 0.005
Atopic dermatitis No 1.000 (reference)
Yes 1.33 (1.13–1.56) <0.001
Aortic dissection No 1.000 (reference)
Yes 1.17 (0.24–5.75) 0.853
Sleep apnea No 1.000 (reference)
Yes 1.28 (0.42–3.92) 0.675
Collagen vascular
diseases No 1.000 (reference)
Yes 1.31 (0.26–6.65) 0.751
Diabetes mellitus No 1.000 (reference)
Yes 1.35 (1.15–1.58) <0.001
Variables for
matching
Sex Male 1.000 (reference)
Female 0.92 (0.82–1.03) 0.135
Age group ≤19 1.000 (reference)
20–59 1.15 (0.97–1.36) 0.092
≥60 1.01 (0.81–1.26) 0.495
Income Low 1.000 (reference)
Middle 0.98 (0.84–1.15) 0.831
High 0.94 (0.80–1.09) 0.337
Residential area Metropolitan 1.000 (reference)
City 0.95 (0.77–1.19) 0.756
Rural 0.96 (0.78–1.17) 0.744
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,e present study, based on reliable and numerous
population groups, supported the positive correlation of
keratoconus and allergic diseases. ,is study is one of the few
studies that has investigated the epidemiology of keratoconus
in the Korean population. However, there were some limi-
tations to our study.,e prevalence of keratoconus was lower
than expected in some diseases, especially in mitral valve
prolapse and Down syndrome, so the necessity of better-
designated control groups is indicated. Moreover, it suggests
the need for further investigations regarding other parame-
ters, such as eye rubbing or sleep positions.
,ere are several limitations to consider when interpreting
the results of our study. First, the diagnosis of keratoconus was
entirely based on the KCD code system which may be inac-
curate compared to the diagnosis made with a standardized
diagnostic measurement. To overcome such limitations, we
included those who had diagnostic code for keratoconus and
underwent keratometry measurement, whichmay enhance the
specificity of the keratoconus subjects included in this study.
Second, it is possible that the OAG patients may have been
underestimated because the data are based on hospital visits.
,e data do not include initial patients who did not experience
symptoms and patients who do not visit the hospital for
economic reasons. However, the degree of underestimation is
limited due to the low cost and high accessibility of the Korean
medical system, a government-run healthcare system in-
cluding nearly the entire population of South Korea.,erefore,
it is unlikely that inaccuracy and underestimation of the di-
agnosis affected the statistical results. ,ird, our data include
only data for the Korean population, and there may be dif-
ferences in other ethnic groups.
In summary, statistical analysis showed a significant
association between keratoconus and atopic diseases such as
allergic rhinitis, asthma, and atopic dermatitis. Considering
the incidence of keratoconus with the above comorbid
conditions, studies investigating this association may help in
the planning of eye-care policies. However, conflicting re-
sults regarding the possible association between keratoconus
and DM should be further evaluated.
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